October 2020

MPCCC brings personalised cancer medicine to people in south-eastern Victoria

Molecular profiling of solid tumours is now more accessible for people with cancer, who are being treated across south-eastern Victoria, following the establishment of the MPCCC Precision Oncology Program. 

Over 80 patients with rare, therapy-resistant or advanced stage cancers have already been referred for screening through the MPCCC across a range of tumour streams, including including upper gastrointestinal, liver, pancreas, biliary, colorectal, thyroid, breast, gynaecological, lung, skin and cancers of unknown primary.

Continue reading »

Victoria’s most outstanding mid-career cancer researchers announced: register for our winners' seminar

MPCCC is excited to announce the prize winners of its inaugural State-wide search for Outstanding Cancer Research and to acknowledge the highly ranked nominees with an honourable mention. Continue reading »

The winners of this prestigious award, Dr Pouya Faridi and Associate Professor Renea Taylor, will present their winning research at 1-2 pm on Friday 13 November at our winners' webinar. Register here »

Register for 2020 SMICS Annual Forum

The Southern Melbourne Integrated Cancer Service (SMICS) 2020 Annual Forum 
“Ethical Considerations” will be held on Monday 7 December 2020 featuring keynote speaker Professor Clare Delaney, addressing ethical considerations in cancer care during and beyond COVID-19.  We will also showcase the pilot of a newly developed radiological report to define resectability of non metastatic pancreatic ductal adenocarcenoma (PDAC) with Dr Charles Pilgrim and Associate Professor Samantha Ellis.

Register for forum

Monash discoveries suggest new breast cancer treatment

Findings by Monash Biomedicine Discovery Institute (BDI) researchers have pointed to a new combination of treatments that may help breast cancer patients with certain gene mutations. The study, published in Molecular Cell and led by Dr Antonella Papa, identified potential new treatments for patients who lacked PTEN, a gene that suppresses tumours, and/or have mutations in the cancer gene PI3K. Continue reading »

Fertility hope for testicular cancer patients

The Alfred has banded together with a private IVF company to save a patient's chance of having children after he was diagnosed with testicular cancer. A 33-year-old man was recently treated at The Alfred after he was diagnosed with cancer in both testicles as well as a metastasis in the abdomen. Both testicles had to be removed. Continue reading »

Breast Cancer Awareness Month: A mother’s story 

It was a moment in time she didn’t see coming, someone else’s story but it was happening to her. When mum-of-three Sophia* was diagnosed with breast cancer in December 2018, it felt surreal. She’d gone to the GP for a routine check-up and was referred for a mammogram due to her age. Continue reading »

BreastScreen leading tomosynthesis screening study

Maroondah BreastScreen was the host site for the first feasibility study on the outcomes of tomosynthesis screening (a type of mammography that creates 3D images of the breast) in the Australian BreastScreen setting. Continue reading »

Cancer doesn’t stop for COVID

Between April and June this year, notifications of breast cancers decreased almost forty percent. Head of our breast surgery unit Dr Melanie Walker said, the COVID-19 restrictions should not be deterring people from seeing their GP for a breast examination if they have symptoms or concerns.  
Continue reading »

Telehealth Cancer Support Nurse Review Clinic at Monash Health

Monash Health commenced a Telehealth Cancer Support Nurse, Review Clinic on
5 October, for patients who experience symptoms from their cancer or cancer therapy. The Nurse Led clinic will provide accurate assessment, triage, education, support and intervention to intensify management of poorly controlled symptoms at home.  Continue reading »

GenesisCare celebrated their 1st Anniversary at the Cabrini Malvern Gandel Wing

The GenesisCare oncology team recently celebrated their first birthday within the Gandel Wing building at Cabrini, Malvern. The team moved their service over last year from their unique purpose-built temporary treatment centre at Cabrini to the state-ofthe-art department in the Gandel Wing. Continue reading »

Cancer and COVID-19 in Victoria: Challenges and Perspectives from the USA

The Victorian COVID-19 Cancer Network is delighted to welcome Dr Ziad Bakouny, Dana-Farber Cancer Institute, Boston USA, who will highlight the biological interplay between the two diseases and provide practical recommendations for the treatment of patients with cancer during the pandemic.

Friday 6 November, 1-2pm
Register for webinar »

MPCCC Tech Talk: A/Prof Bernie Pope

At this Tech Talk, Associate Professor Bernie Pope will present on the topic 'somatic variant calling in whole genome sequencing, opportunities, challenges and solutions.'

A/Prof Bernie Pope is a Victorian Health and Medical Research Fellow at Melbourne Bioinformatics within the University of Melbourne. 

Friday 20 November, 1-2pm
Register for webinar »

MPCCC Precision Oncology Seminar: Prof Tony Purcell

At this Precision Oncology Seminar, Professor Tony Purcell will discuss the topic 'Insights into the tumour immunopeptidome and its role in personalized immunotherapy.'

Prof Tony Purcell is an NHMRC Principal Research Fellow and Deputy Head (Research) of the Department of Biochemistry at Monash University

Friday 27 November, 1-2pm
Register for webinar »

National Pancreatic Cancer Roadmap

Cancer Australia is inviting the public to have their say on the National Pancreatic Cancer Roadmap through a dedicated Consultation Hub. All interested stakeholders are invited to have their say. The National Pancreatic Cancer Roadmap will identify key priority areas for action over the next five years to improve outcomes for people with pancreatic cancer. It will consider all aspects of the cancer pathway, including prevention, early detection, diagnosis, treatment, supportive and palliative care. The Consultation Hub will be open until 30 November 2020. Read more and have your say »

MRFF Emerging Priorities and Consumer Driven Research Initiative – 2020 Childhood Cancer Research Grant
This funding scheme aims to provide grants of financial assistance to support  medical research and medical innovation projects that improve our understanding of the aetiology, biology and progression of cancer in children and adolescents. $9 million is available in this funding pool, and applications close on 3rd February 2021Apply now »

MRFF Clinical Trial Activity Initiative - 2020 International Clinical Trial Collaborations Grant Opportunity 
Applicants to this funding scheme must propose a clinical trial in Australia, in collaboration with international counterparts. $12.6 million is available in this funding pool, and round 2 applications close on 3rd March 2020.  Apply now »

All those interested in applying for these grants can contact Karen McConalogue for application support on

Participate in the 2020 Repeat Prostate Cancer Summit

The Repeat Prostate Cancer Summit will provide an opportunity to explore changes in care since the initial 2016 summit and draw upon clinician and consumer expertise to identify priorities for improvement in Victoria.  We are fortunate to have access to data from the DHHS and the Prostate Cancer Outcomes Registry to share at the Summit.  It will be held on the following two dates online. Register here » 

Friday 4th December 2.30-4.30pm &

Friday 11th December 2.30-4.30pm

For queries, email:  or speak with Victorian Tumour Summits project manager Janine Scott on 0422 225 996.  

Demystifying the Molecular Tumour Board

This will be a masterclass series of 4 self-contained webinars held over 4 consecutive Thursday afternoons 4-5pm from 29th October 2020 to 19th November 2020. Each webinar will focus on one or more specific aspects of tumour molecular profiling that are the subject of MTB discussion. These files will also be available after the event. Register here » 

MPCCC Precision Oncology Seminar: Dr Nic Waddell

If you missed this seminar, you can watch the recording to hear Dr Nic Waddell discuss insights from cancer and genome sequencing. Dr Waddell is head of the Medical Genomics group at QIMR Berghofer Medical Research Institute, Queensland.
Watch now » 

Cancer and COVID-19 in Victoria: unpacking the complexity of providing palliative care services during a pandemic

If you missed this Victorian COVID-19 Cancer Network Cancer Network webinar, you can watch the recording to hear a panel of experts from across the Victorian cancer sector discuss current challenges associated with palliative care.  Watch now » 

Demystifying the Molecular Tumour Board
When: 4.00-5.00pm
Thursday 29 October - Thursday 19 November (weekly)
More information and registration

Cancer and COVID-19 in Victoria: Challenges and perspectives from the USA
When: 1.00-2.0pm
Friday 6 November
More information and registration
MPCCC Award for Outstanding Cancer Research in Victoria: Winners' Seminar
When: 1.00-2.00pm,
Friday 13 November
More information and registration

MPCCC Tech Talk: A/Prof Bernie Pope
When: 1.00-2.00pm,
Friday 20 November
More information and registration

MPCCC Precision Oncology Seminar: Prof Tony Purcell
When: 1.00-2.00pm, Friday 27 November
More information and registration

Teletrials: implementation of a new paradigm for clinical trials. Read article »

Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer. Read article »

Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma. Read article »

A single-domain bispecific antibody targeting CD1d and the NKT T-cell receptor induces a potent antitumor response. Read article »

Immunopeptidomic Analysis Reveals That Deamidated HLA-bound Peptides Arise Predominantly from Deglycosylated Precursor. Read article »

‘Multi-omics’ adds new cell to immune family treeContinue reading »

Australia’s first strategic action plan for blood cancers. Continue reading »
Monash Partners Comprehensive Cancer Consortium (MPCCC) is a strategic alliance of health service and research organisations working in partnership to improve cancer outcomes through integrated, collaborative and innovative research, service improvement and clinical care programs. We are a consortium made up of clinical, research and allied partner organisations. 
Clinical partners
Alfred Health; Monash Health; Eastern Health; Peninsula Health; 
Cabrini Health; Epworth HealthCare

Research partners
Monash University; Hudson Institute of Medical Research

Allied partners
Southern Melbourne Integrated Cancer Service (SMICS); 
Monash Partners Academic Health Science Centre (Monash Partners).
If you would like to contribute to the MPCCC e-Newsletter email
Copyright © 2020 MPCCC, All rights reserved.